John M. McLaughlin

7.3k total citations · 5 hit papers
105 papers, 4.3k citations indexed

About

John M. McLaughlin is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, John M. McLaughlin has authored 105 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 39 papers in Health and 35 papers in Epidemiology. Recurrent topics in John M. McLaughlin's work include SARS-CoV-2 and COVID-19 Research (45 papers), Vaccine Coverage and Hesitancy (38 papers) and COVID-19 Clinical Research Studies (25 papers). John M. McLaughlin is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (45 papers), Vaccine Coverage and Hesitancy (38 papers) and COVID-19 Clinical Research Studies (25 papers). John M. McLaughlin collaborates with scholars based in United States, Israel and United Kingdom. John M. McLaughlin's co-authors include Luis Jódar, David L. Swerdlow, Farid Khan, Frederick J. Angulo, Sara Y. Tartof, Bradley K. Ackerson, Vennis Hong, Kaijie Pan, Jeff Slezak and Jo Southern and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

John M. McLaughlin

99 papers receiving 4.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

2021 1.0k citations Eric J. Haas, Frederick J. Angulo et al. profile →
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

2021 727 citations Sara Y. Tartof, Jeff Slezak et al. profile →
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis

2022 116 citations John M. McLaughlin, Farid Khan et al. Open Forum Infectious Diseases profile →
Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

2023 83 citations Timothy L. Wiemken, Farid Khan et al. Scientific Reports profile →
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system

2023 74 citations John M. McLaughlin, Vennis Hong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John M. McLaughlin United States	29	2.3k	1.3k	1.1k	726	413	105	4.3k
Amanda Cohn United States	30	1.3k 0.6×	994 0.8×	2.1k 1.9×	404 0.6×	439 1.1×	84	4.5k
Manish Pareek United Kingdom	32	1.9k 0.8×	568 0.5×	1.6k 1.5×	353 0.5×	394 1.0×	152	4.0k
Kathleen Dooling United States	26	1.4k 0.6×	1.1k 0.9×	1.5k 1.4×	382 0.5×	178 0.4×	66	3.6k
Jim McMenamin United Kingdom	34	1.6k 0.7×	755 0.6×	2.3k 2.1×	639 0.9×	183 0.4×	109	4.0k
Ryan Gierke United States	20	2.2k 1.0×	546 0.4×	2.0k 1.8×	590 0.8×	862 2.1×	34	5.8k
Julianne Gee United States	32	1.9k 0.8×	1.9k 1.5×	1.7k 1.5×	216 0.3×	307 0.7×	74	4.6k
H. Keipp Talbot United States	47	3.4k 1.5×	1.8k 1.4×	4.6k 4.1×	832 1.1×	276 0.7×	165	8.4k
Sara E. Oliver United States	20	1.6k 0.7×	1.0k 0.8×	677 0.6×	384 0.5×	159 0.4×	54	2.9k
Gavin Dabrera United Kingdom	17	2.2k 1.0×	857 0.7×	576 0.5×	741 1.0×	146 0.4×	61	3.2k
Stephanie R. Bialek United States	35	2.2k 0.9×	379 0.3×	3.3k 3.0×	493 0.7×	663 1.6×	86	6.4k

Countries citing papers authored by John M. McLaughlin

Since Specialization

Citations

This map shows the geographic impact of John M. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. McLaughlin more than expected).

Fields of papers citing papers by John M. McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. McLaughlin. The network helps show where John M. McLaughlin may publish in the future.

Co-authorship network of co-authors of John M. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of John M. McLaughlin. A scholar is included among the top collaborators of John M. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. McLaughlin. John M. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Appaneal, Haley J., Vrishali V. Lopes, Laura Puzniak, et al.. (2025). Early effectiveness of the BNT162b2 KP.2 vaccine against COVID-19 in the US Veterans Affairs Healthcare System. Nature Communications. 16(1). 4033–4033. 4 indexed citations

Rudolph, Abby E., et al.. (2025). Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review. Human Vaccines & Immunotherapeutics. 21(1). 2474772–2474772. 2 indexed citations

Appaneal, Haley J., Kerry L. LaPlante, Vrishali V. Lopes, et al.. (2024). Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System. Infectious Diseases and Therapy. 13(1). 155–172. 8 indexed citations

Caffrey, Aisling R., Haley J. Appaneal, Vrishali V. Lopes, et al.. (2024). Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System. Nature Communications. 15(1). 9490–9490. 12 indexed citations

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2024). Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 Sublineages. Open Forum Infectious Diseases. 11(7). ofae370–ofae370. 7 indexed citations

Gavaghan, Meghan, Jingyan Yang, Richard H. Stanford, et al.. (2024). Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization and Mortality: A Systematic Literature Review. American Journal of Therapeutics. 31(3). e246–e257. 3 indexed citations

Weber, David J., Kanecia O. Zimmerman, Sara Y. Tartof, John M. McLaughlin, & Shanti Pather. (2024). Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review. Vaccines. 12(9). 989–989.

Penrose, Kate, Yanhan Shen, McKaylee Robertson, et al.. (2024). Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults. Infectious Diseases and Therapy. 13(8). 1743–1757.

Oordt-Speets, Anouk, et al.. (2023). Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review. SHILAP Revista de lepidopterología. 3(10). 1516–1527. 10 indexed citations

10.

Wiemken, Timothy L., Farid Khan, Laura Puzniak, et al.. (2023). Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Scientific Reports. 13(1). 3886–3886. 83 indexed citations breakdown →

11.

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2023). Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System. JAMA Network Open. 6(1). e2251833–e2251833. 18 indexed citations

12.

Stoner, Marie C. D., Frederick J. Angulo, Sarah Rhea, et al.. (2022). Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021. Open Forum Infectious Diseases. 9(2). ofab647–ofab647. 5 indexed citations

13.

Yang, Jingyan, Benjamin Yarnoff, Manuela Di Fusco, et al.. (2022). Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert Review of Vaccines. 22(1). 54–65. 17 indexed citations

14.

Haas, Eric J., Frederick J. Angulo, John M. McLaughlin, Emilia Anis, & Luis Jódar. (2021). Nationwide Vaccination Campaign with BNT162b2 in Israel Demonstrates High Vaccine Effectiveness and Marked Declines in Incidence of SARS-CoV-2 Infections and COVID-19 Cases, Hospitalizations, and Deaths (preprint). SSRN Electronic Journal. 3 indexed citations

15.

Istúriz, Raúl, John M. McLaughlin, Vincenza Snow, et al.. (2017). Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age. Expert Review of Vaccines. 17(1). 45–55. 12 indexed citations

16.

McLaughlin, John M., et al.. (2017). Predictors of quality of life among adolescents and young adults with a bleeding disorder. Health and Quality of Life Outcomes. 15(1). 67–67. 26 indexed citations

17.

Paskett, Electra D., Katherine W. Reeves, John M. McLaughlin, et al.. (2008). Recruitment of minority and underserved populations in the United States: The centers for population health and health disparities experience. Contemporary Clinical Trials. 29(6). 847–861. 153 indexed citations

18.

McLaughlin, John M., et al.. (1995). Education as an Industry: Opportunities for Public Schools.. School business affairs. 61(11). 10–14.

19.

McLaughlin, John M.. (1995). Public Education and Private Enterprise: Where's This New Relationship Going?.. The School Administrator. 52(7). 6. 3 indexed citations

20.

Moore, Charles E. & John M. McLaughlin. (1992). Interactive two-way television: extending the classroom through technology. T.H.E. Journal Technological Horizons in Education. 19(7). 74–76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact